Results 31 to 40 of about 109,637 (271)
Frontiers in Cellular and Infection Microbiology, 2021 Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving more than 300 million people at risk of infection.
Greta Volpedo +5 more
semanticscholar +1 more source
Microorganisms, 2023 A relevant aspect in the epidemiology of Tegumentary Leishmaniasis (TL) are the Leishmania parasites carrying a viral endosymbiont, Leishmania RNA Virus 1 (LRV1), a dsRNA virus.
Mayara Cristhine de Oliveira Santana +3 more
doaj +1 more source
Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
Microorganisms, 2021 Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers.
J. M. Curtin, N. Aronson
semanticscholar +1 more source
Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review
PLoS Neglected Tropical Diseases, 2021 Cutaneous leishmaniasis has been endemic since decades. Millions of cases are reported worldwide specially in developing and underdeveloped countries. There are 2 major types of cutaneous leishmaniasis based on the causating species found in different ...
M. Azim +4 more
semanticscholar +1 more source
Clinical Case Reports, 2021 Clinicians should always consider rare, atypical, and opportunistic infections in patients undergoing long‐term systemic corticosteroid therapy. Diagnosis needs further evaluations and special consideration.
Maryam Mahdavi +4 more
doaj +1 more source
The global procurement landscape of leishmaniasis medicines
PLoS Neglected Tropical Diseases, 2021 Ensuring access to essential medicines for leishmaniasis control is challenging, as leishmaniasis is a very small and unattractive market for pharmaceutical industry. Furthermore, control programmes are severely underfunded.
H. Choi +4 more
semanticscholar +1 more source
Leishmaniasis Worldwide and Global Estimates of Its Incidence
PLoS ONE, 2012 As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective ...
J. Alvar +7 more
semanticscholar +1 more source
Expert Review of Vaccines, 2021 Introduction Leishmaniasis is a major public health problem and the second most lethal parasitic disease in the world due to the lack of effective treatments and vaccines.
Greta Volpedo +7 more
semanticscholar +1 more source
Gates Open Research, 2019 Visceral leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania protozoa that are transmitted by female sand flies. On the Indian subcontinent (ISC), VL is targeted by the World Health Organization (WHO) for elimination as a public
NTD Modelling Consortium Visceral Leishmaniasis Group
doaj +1 more source
Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice
Parasites & Vectors, 2020 Background Leishmaniasis is a serious health problem in some parts of the world. In spite of the many known leishmaniasis control measures, the disease has continued to increase in endemic areas, and no effective vaccine has been discovered.
Samira Salari +3 more
doaj +1 more source